Sentence examples for cells intervention from inspiring English sources

Various etiopathogenetic hypothesis were proposed: mucosal and/or systemic inflammation [ 19, 34], altered signalling to the tight junctions [ 35], serum neurotensin increase [ 36], mast cells intervention [ 37], molecular mimicry between peptides of dietary gliadin, and a cerebellar peptide, for example, brain protein of Purkinje cells [ 20, 21].

Such a mechanism of action offers a large therapeutic window for post-stroke stem cell intervention.

Regional benefit of iPS cell intervention translates into improved left ventricular conduction and contractility, reduced scar and reversal of structural remodeling, protecting against organ decompensation [10].

The link between HPV16 and cervical carcinoma opens up the possibility of immune T-cell intervention, either against the preinvasive lesions from which tumours arise, or against the virus antigen-positive tumour cells themselves.

Our observations herein also portend beneficial outcomes when considering tolerogenic dendritic cell intervention in autoimmune diseases such as type 1 diabetes at a time closer to the clinical onset of the disease.

Such unproven stem cell interventions also raise the significant risk of placebo effects being mistaken for genuine cures, and could stymie progress in the field.

In contrast others are concerned that early adoption of unproven stem cell interventions, outside ethical review and the clinical trials processes, places individuals at risk of personal harm.

Then, reactive scheduling is used to schedule dendritic cell interventions with and without interleukin interventions under the varying conditions of the patient.

Some bioethicists argue that the distinction between somatic cell and germ-line GM has moral significance, and that somatic cell interventions alone are permissible.

It is beginning to surpass the ability of patients to make informed decisions, especially around new emerging biotechnologies such as stem cell interventions and genome sequencing.

Although there is still a role for assessment of innovative medical treatment using unproven stem cell interventions - like the initial 1957 hematopoietic and 1981 skin stem cell grafts - this approach should be considered as a 'one-off' and not offered widely or commercially until proven safe and effective.